At a glance
ClinicalIndex Comparison RecordN/ACompleted· 330 enrolled
Drug / intervention
EV1000 Clinical Platform with Assisted Fluid Management (AFM) Featuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Validation of the Assisted Fluid Management Feature
In Brief
A clinical study evaluating EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature for Non-Cardiac/ Non-Thoracic Surgery and 3 related conditions. Completed, enrolled 330 participants across 10 sites.
Detailed Summary
The primary objective of this study is to evaluate the performance of the Acumen™ Assisted Fluid Management (AFM) Feature in its ability to predict a subject's fluid responsiveness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-Cardiac/ Non-Thoracic Surgery, Abdominal Surgery, Pelvic Surgery, Major Peripheral Vascular Surgery
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 2018
Enrollment StartApr 2018
Primary CompletionDec 2018
Study CompletionJan 2019
TodayJul 2026
First PostedMar 19, 2018
Enrollment StartApr 19, 2018
Primary CompletionDec 21, 2018
Study CompletionJan 25, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.3 years ago
Interventions
EV1000 Clinical Platform with Assisted Fluid Management (AFM) Featuredevice
Subjects enrolled in the validation study will have their fluid management decisions guided by the AFM Feature.